Italia markets closed

LifeStance Health Group, Inc. (LFST)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
5,33-0,21 (-3,75%)
Al 01:06PM EST. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente5,54
Aperto5,47
Denaro5,34 x 900
Lettera5,35 x 800
Min-Max giorno5,32 - 5,60
Intervallo di 52 settimane4,22 - 11,25
Volume108.426
Media Volume519.295
Capitalizzazione2,005B
Beta (5 anni mensile)N/D
Rapporto PE (ttm)N/D
EPS (ttm)-1,07
Prossima data utili08 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A7,92
  • GlobeNewswire

    LifeStance to Present at the 41st Annual J.P. Morgan Healthcare Conference

    SCOTTSDALE, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference, which will be hosted in San Francisco, CA. Details of the presentation are as follows:Presenters: Ken Burdick, Chairman and CEO, and Danish Qureshi, President and COODate: Tuesday, January 10, 2023 Time: 7:30 a.m. (Pacifi

  • GlobeNewswire

    LifeStance to Present in the 41st Annual J.P. Morgan Healthcare Conference

    SCOTTSDALE, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference, which will be hosted in San Francisco, CA. Details of the presentation are as follows:Presenters: Ken Burdick, Chairman and CEO, and Danish Qureshi, President and COODate: Tuesday, January 10, 2023 Time: 7:30 a.m. (Pacifi

  • GlobeNewswire

    LifeStance Reports Third Quarter 2022 Results

    SCOTTSDALE, Ariz., Nov. 08, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the quarter ended September 30, 2022. (All results compared to prior-year comparative period, unless otherwise noted) Q3 2022 Highlights and FY 2022 Outlook Revenue of $217.6 million increased $43.8 million or 25% compared to revenue of $173.8 millionTotal clinicians of 5,431 up 24%, a net i